{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:14:38Z","timestamp":1790198078004,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Selcuk University Scientific Research Project Office","award":["22401070"],"award-info":[{"award-number":["22401070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study aimed to investigate endothelial glycocalyx (eGCx) damage in cats with feline hemotropic mycoplasmosis caused by <jats:italic>Mycoplasma haemofelis<\/jats:italic> using selected biomarkers and to determine the diagnostic and prognostic significance of these biomarkers. The study included 25 cats with feline hemotropic mycoplasmosis and 10 healthy cats. Clinical examination, blood gas analysis, complete blood count, and biochemical analysis were performed. Hemotropic mycoplasmosis diagnosed by microscopic examination and molecularly confirmed by PCR targeting the <jats:italic>Mycoplasma haemofelis 16s rRNA<\/jats:italic> gene. To evaluate endothelial glycocalyx damage, syndecan-1, endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA), and vascular endothelial growth factor-A (VEGF-A) concentrations were measured using cat-specific commercial ELISA kits. Of the cats with feline hemotropic mycoplasmosis, 14 (56%) survived and 11 (44%) died. While syndecan-1 and ET-1 concentrations were significantly higher in cats with hemotropic mycoplasmosis compared to the control group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), no statistically significant difference was found for ADMA and VEGF-A concentrations (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Endothelial glycocalyx biomarkers showed significant correlations with each other and with hematological parameters (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). The results of the ROC analysis showed that ET-1 with area under the curve (AUC) of 0.821 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and VEGF-A with AUC of 0.805 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.010) were found to be significant prognostic indicators. In conclusion, this study demonstrated that serum syndecan-1 and ET-1 can be used as diagnostic and serum ET-1 and VEGF-A as prognostic biomarkers in cats with hemotropic mycoplasmosis. Our results indicate the development of eGCx damage in feline hemotropic mycoplasmosis and suggest that glycocalyx disruption may contribute to the pathogenesis of the disease.<\/jats:p>","DOI":"10.1038\/s41598-024-62359-7","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:08:54Z","timestamp":1717592934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of endothelial glycocalyx injury biomarkers in feline hemotropic mycoplasmosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Merve","family":"Ider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceylan","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat Kaan","family":"Durgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman Serhat","family":"Iyigun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra Burcu","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Betul","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Cansu","family":"Kilickaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"62359_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.micinf.2005.08.015","volume":"8","author":"S Tasker","year":"2006","unstructured":"Tasker, S. et al. Effect of chronic feline immunodeficiency infection, and efficacy of marbofloxacin treatment, on \u201cCandidatus Mycoplasma Haemominutum\u201d infection. Microbes Infect. 8, 653\u2013661. https:\/\/doi.org\/10.1016\/j.micinf.2005.08.015 (2006).","journal-title":"Microbes Infect."},{"key":"62359_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1476-4431.2009.00491.x","volume":"20","author":"JE Sykes","year":"2010","unstructured":"Sykes, J. E. Feline hemotropic mycoplasmas. J. Vet. Emerg. Crit. Care 20, 62\u201369 (2010).","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"62359_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma, S., Slaaf, D. W., Vink, H., Van-Zandvoort, M. A. & Oude-Egbrink, M. G. The endothelial glycocalyx: Composition, functions, and visualization. Pflugers Arch. 454, 345\u2013359. https:\/\/doi.org\/10.1007\/s00424-007-0212-8 (2007).","journal-title":"Pflugers Arch."},{"key":"62359_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu15112573","volume":"2023","author":"P Francekovic","year":"2023","unstructured":"Francekovic, P. & Gliemann, L. Endothelial glycocalyx preservation-impact of nutrition and lifestyle. Nutrients 2023, 15. https:\/\/doi.org\/10.3390\/nu15112573 (2023).","journal-title":"Nutrients"},{"key":"62359_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.acmx.2013.04.015","volume":"83","author":"AC Frati-Munari","year":"2013","unstructured":"Frati-Munari, A. C. Medical significance of endothelial glycocalyx. Arch. Cardiol. Mex. 83, 303\u2013312. https:\/\/doi.org\/10.1016\/j.acmx.2013.04.015 (2013).","journal-title":"Arch. Cardiol. Mex."},{"key":"62359_CR6","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.3390\/ijms22062996","volume":"22","author":"V Masola","year":"2021","unstructured":"Masola, V., Zaza, G., Arduini, A., Onisto, M. & Gambaro, G. Endothelial glycocalyx as a regulator of fibrotic processes. Int. J. Mol. Sci. 22, 2996 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"62359_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/CM9.0000000000000177","volume":"132","author":"RN Cao","year":"2019","unstructured":"Cao, R. N., Tang, L., Xia, Z. Y. & Xia, R. Endothelial glycocalyx as a potential theriapeutic target in organ injuries. Chin. Med. J. (Engl.) 132, 963\u2013975. https:\/\/doi.org\/10.1097\/CM9.0000000000000177 (2019).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"62359_CR8","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1152\/ajpheart.00006.2016","volume":"310","author":"IP Torres-Filho","year":"2016","unstructured":"Torres-Filho, I. P., Torres, L. N., Salgado, C. & Dubick, M. A. Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids. Am. J. Physiol. Heart Circ. Physiol. 310, 1468\u20131478. https:\/\/doi.org\/10.1152\/ajpheart.00006.2016 (2016).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"62359_CR9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41598-020-80385-z","volume":"11","author":"BE Barber","year":"2021","unstructured":"Barber, B. E. et al. Endothelial glycocalyx degradation and disease severity in and malaria. Sci. Rep.-Uk 11, 458 (2021).","journal-title":"Sci. Rep.-Uk"},{"key":"62359_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00424-020-02407-z","volume":"472","author":"M Lipphardt","year":"2020","unstructured":"Lipphardt, M., Song, J. W. & Goligorsky, M. S. Sirtuin 1 and endothelial glycocalyx. Pflugers Arch. 472, 991\u20131002. https:\/\/doi.org\/10.1007\/s00424-020-02407-z (2020).","journal-title":"Pflugers Arch."},{"key":"62359_CR11","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/cc9025","volume":"14","author":"LA Mankhambo","year":"2010","unstructured":"Mankhambo, L. A. et al. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit. Care 14, R91. https:\/\/doi.org\/10.1186\/cc9025 (2010).","journal-title":"Crit. Care"},{"key":"62359_CR12","doi-asserted-by":"publisher","first-page":"ofab302","DOI":"10.1093\/ofid\/ofab302","volume":"8","author":"A Frimpong","year":"2021","unstructured":"Frimpong, A. et al. Elevated levels of the endothelial molecules ICAM-1, VEGF-A, and VEGFR2 in microscopic asymptomatic malaria. Open Forum Infect Dis. 8, ofab302. https:\/\/doi.org\/10.1093\/ofid\/ofab302 (2021).","journal-title":"Open Forum Infect Dis."},{"key":"62359_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1179\/2047773214y.0000000130","volume":"108","author":"M Canavese","year":"2014","unstructured":"Canavese, M. & Spaccapelo, R. Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria. Pathog. Glob. Health 108, 67\u201375. https:\/\/doi.org\/10.1179\/2047773214y.0000000130 (2014).","journal-title":"Pathog. Glob. Health"},{"key":"62359_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccc.2019.12.001","volume":"36","author":"S Pons","year":"2020","unstructured":"Pons, S. et al. Immune consequences of endothelial cells\u2019 activation and dysfunction during sepsis. Crit. Care Clin. 36, 401\u2013413. https:\/\/doi.org\/10.1016\/j.ccc.2019.12.001 (2020).","journal-title":"Crit. Care Clin."},{"key":"62359_CR15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/cid\/ciz038","volume":"69","author":"TW Yeo","year":"2019","unstructured":"Yeo, T. W. et al. Glycocalyx breakdown is associated with severe disease and fatal outcome in Plasmodium falciparum malaria. Clin. Infect. Dis. 69, 1712\u20131720 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"62359_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11897-017-0320-5","volume":"14","author":"Y-H Kim","year":"2017","unstructured":"Kim, Y.-H., Nijst, P., Kiefer, K. & Tang, W. W. Endothelial glycocalyx as biomarker for cardiovascular diseases: Mechanistic and clinical implications. Curr. Heart Fail. Rep. 14, 117\u2013126 (2017).","journal-title":"Curr. Heart Fail. Rep."},{"key":"62359_CR17","doi-asserted-by":"publisher","first-page":"e12654","DOI":"10.1111\/micc.12654","volume":"28","author":"H Okada","year":"2021","unstructured":"Okada, H., Yoshida, S., Hara, A., Ogura, S. & Tomita, H. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection. Microcirculation 28, e12654 (2021).","journal-title":"Microcirculation"},{"key":"62359_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4067\/S0719-81322020000300095","volume":"52","author":"A Naseri","year":"2020","unstructured":"Naseri, A. et al. Serum biomarkers of endothelial glycocalyx injury in canine parvoviral infection. Austral J. Vet. Sci. 52, 95\u2013101 (2020).","journal-title":"Austral J. Vet. Sci."},{"key":"62359_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12959-021-00258-x","volume":"19","author":"K Suzuki","year":"2021","unstructured":"Suzuki, K. et al. Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury. Thromb. J. 19, 5. https:\/\/doi.org\/10.1186\/s12959-021-00258-x (2021).","journal-title":"Thromb. J."},{"key":"62359_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2460\/ajvr.2001.62.604","volume":"62","author":"WA Jensen","year":"2001","unstructured":"Jensen, W. A., Lappin, M. R., Kamkar, S. & Reagan, W. J. Use of a polymerase chain reaction assay to detect and differentiate two strains of Haemobartonella felis in naturally infected cats. Am. J. Vet. Res. 62, 604\u2013608. https:\/\/doi.org\/10.2460\/ajvr.2001.62.604 (2001).","journal-title":"Am. J. Vet. Res."},{"key":"62359_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ttbdis.2017.03.007","volume":"8","author":"T Masatani","year":"2017","unstructured":"Masatani, T. et al. Detection and molecular characterization of Babesia, Theileria, and Hepatozoon species in hard ticks collected from Kagoshima, the southern region in Japan. Ticks Tick Borne Dis. 8, 581\u2013587. https:\/\/doi.org\/10.1016\/j.ttbdis.2017.03.007 (2017).","journal-title":"Ticks Tick Borne Dis."},{"key":"62359_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1469-0691.2010.03316.x","volume":"17","author":"S Harrus","year":"2011","unstructured":"Harrus, S. et al. Molecular detection of Ehrlichia canis, Anaplasma bovis, Anaplasma platys, Candidatus Midichloria mitochondrii and Babesia canis vogeli in ticks from Israel. Clin. Microbiol. Infect. 17, 459\u2013463. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03316.x (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"62359_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1128\/JCM.42.1.90-98.2004","volume":"42","author":"MB Labruna","year":"2004","unstructured":"Labruna, M. B. et al. Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of Sao Paulo, Brazil, where Brazilian spotted fever is endemic. J. Clin. Microbiol. 42, 90\u201398 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"62359_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1939-165X.2009.00158.x","volume":"38","author":"AP Santos","year":"2009","unstructured":"Santos, A. P. et al. Design, optimization, and application of a conventional PCR assay with an internal control for detection of \u201cCandidatus Mycoplasma turicensis\u201d 16S rDNA in domestic cats from Brazil. Vet. Clin. Pathol. 38, 443\u2013452. https:\/\/doi.org\/10.1111\/j.1939-165X.2009.00158.x (2009).","journal-title":"Vet. Clin. Pathol."},{"key":"62359_CR25","first-page":"401","volume":"15","author":"M Ider","year":"2022","unstructured":"Ider, M., Durgut, M. K., Iyigun, S. S., Ceylan, C. & K\u0131l\u0131ckaya, M. C. Evaluation of some blood gas, hemogram and biochemical parameters in cats with hemoplasmosis. Kocatepe Vet. J. 15, 401\u2013411 (2022).","journal-title":"Kocatepe Vet. J."},{"key":"62359_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2349-4220.159131","volume":"2","author":"VS Dabadghao","year":"2015","unstructured":"Dabadghao, V. S., Singh, V. B., Sharma, D. & Meena, B. L. A study of serum lactate level in malaria and its correlation with severity of disease. Int. J. Adv. Med. Health Res. 2, 28\u201332 (2015).","journal-title":"Int. J. Adv. Med. Health Res."},{"key":"62359_CR27","doi-asserted-by":"publisher","first-page":"e1009122","DOI":"10.1371\/journal.ppat.1009122","volume":"17","author":"H Possemiers","year":"2021","unstructured":"Possemiers, H., Vandermosten, L. & Van den Steen, P. E. Etiology of lactic acidosis in malaria. PLoS Pathog. 17, e1009122. https:\/\/doi.org\/10.1371\/journal.ppat.1009122 (2021).","journal-title":"PLoS Pathog."},{"key":"62359_CR28","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1016\/j.febslet.2005.09.088","volume":"579","author":"M Mehta","year":"2005","unstructured":"Mehta, M., Sonawat, H. M. & Sharma, S. Malaria parasite-infected erythrocytes inhibit glucose utilization in uninfected red cells. FEBS Lett. 579, 6151\u20136158. https:\/\/doi.org\/10.1016\/j.febslet.2005.09.088 (2005).","journal-title":"FEBS Lett."},{"key":"62359_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2460\/javma.2002.221.250","volume":"221","author":"KL Dowers","year":"2002","unstructured":"Dowers, K. L., Olver, C., Radecki, S. V. & Lappin, M. R. Use of enrofloxacin for treatment of large-form Haemobartonella felis in experimentally infected cats. J. Am. Vet. Med. Assoc. 221, 250\u2013253. https:\/\/doi.org\/10.2460\/javma.2002.221.250 (2002).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"62359_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1590\/S1984-29612016086","volume":"25","author":"JM Raimundo","year":"2016","unstructured":"Raimundo, J. M. et al. Hematological changes associated with hemoplasma infection in cats in Rio de Janeiro, Brazil. Rev. Bras. Parasitol. Vet. 25, 441\u2013449. https:\/\/doi.org\/10.1590\/S1984-29612016086 (2016).","journal-title":"Rev. Bras. Parasitol. Vet."},{"key":"62359_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.23953\/cloud.ijavst.199","volume":"3","author":"N Senthil","year":"2014","unstructured":"Senthil, N. et al. A rare case study on feline mycoplasmosis. Int. J. Adv. Vet. Sci. Technol. 3, 106\u2013108 (2014).","journal-title":"Int. J. Adv. Vet. Sci. Technol."},{"key":"62359_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/MPH.0b013e3181b7eb12","volume":"31","author":"R Thapa","year":"2009","unstructured":"Thapa, R., Biswas, B., Mallick, D., Sardar, S. & Modak, S. Childhood Plasmodium vivax malaria with severe thrombocytopenia and bleeding manifestations. J. Pediatr. Hematol. Oncol. 31, 758\u2013759. https:\/\/doi.org\/10.1097\/MPH.0b013e3181b7eb12 (2009).","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"Suppl 1","key":"62359_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1590\/s0074-02762011000900007","volume":"106","author":"MV Lacerda","year":"2011","unstructured":"Lacerda, M. V., Mourao, M. P., Coelho, H. C. & Santos, J. B. Thrombocytopenia in malaria: Who cares?. Mem. Inst. Oswaldo Cruz 106(Suppl 1), 52\u201363. https:\/\/doi.org\/10.1590\/s0074-02762011000900007 (2011).","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"62359_CR34","first-page":"48","volume":"2016","author":"M Saqib","year":"2016","unstructured":"Saqib, M. et al. Hemato-biochemical analysis and treatment response to enrofloxacin in cats affected with feline hemotropic mycoplasma. Pak. J. Zool. 2016, 48 (2016).","journal-title":"Pak. J. Zool."},{"key":"62359_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-016-0361-x","volume":"47","author":"S Sugiarto","year":"2016","unstructured":"Sugiarto, S. et al. Passive immunization does not provide protection against experimental infection with Mycoplasma haemofelis. Vet. Res. 47, 1\u201314 (2016).","journal-title":"Vet. Res."},{"key":"62359_CR36","first-page":"590","volume":"60","author":"C Weingart","year":"2015","unstructured":"Weingart, C. & Kohn, B. Haemotropic mycoplasmosis in cats: Current aspects regarding prevalence, clinical signs, diagnosis, therapy and prognosis. Kleintierpraxis 60, 590\u2013600 (2015).","journal-title":"Kleintierpraxis"},{"key":"62359_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1939-165x.2005.tb00019.x","volume":"34","author":"JJ Ceron","year":"2005","unstructured":"Ceron, J. J., Eckersall, P. D. & Martynez-Subiela, S. Acute phase proteins in dogs and cats: Current knowledge and future perspectives. Vet. Clin. Pathol. 34, 85\u201399. https:\/\/doi.org\/10.1111\/j.1939-165x.2005.tb00019.x (2005).","journal-title":"Vet. Clin. Pathol."},{"key":"62359_CR38","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/jcp.26766","volume":"234","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Preoperative albumin-to-globulin ratio predicts survival in patients with non-small-cell lung cancer after surgery. J. Cell Physiol. 234, 2471\u20132479. https:\/\/doi.org\/10.1002\/jcp.26766 (2019).","journal-title":"J. Cell Physiol."},{"key":"62359_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10067-018-4292-y","volume":"38","author":"SS Ahn","year":"2019","unstructured":"Ahn, S. S. et al. Clinical role of albumin to globulin ratio in microscopic polyangiitis: A retrospective monocentric study. Clin. Rheumatol. 38, 487\u2013494. https:\/\/doi.org\/10.1007\/s10067-018-4292-y (2019).","journal-title":"Clin. Rheumatol."},{"key":"62359_CR40","first-page":"1","volume":"2021","author":"B Liu","year":"2021","unstructured":"Liu, B. et al. Albumin-globulin ratio is an independent determinant of 28-day mortality in patients with critical illness. Dis. Marker. 2021, 1\u20135 (2021).","journal-title":"Dis. Marker."},{"key":"62359_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.matbio.2011.10.001","volume":"31","author":"YH Teng","year":"2012","unstructured":"Teng, Y. H., Aquino, R. S. & Park, P. W. Molecular functions of syndecan-1 in disease. Matrix Biol. 31, 3\u201316. https:\/\/doi.org\/10.1016\/j.matbio.2011.10.001 (2012).","journal-title":"Matrix Biol."},{"key":"62359_CR42","doi-asserted-by":"publisher","first-page":"e0160894","DOI":"10.1371\/journal.pone.0160894","volume":"11","author":"M Garsen","year":"2016","unstructured":"Garsen, M. et al. Endothelial nitric oxide synthase prevents heparanase induction and the development of proteinuria. PloS one 11, e0160894 (2016).","journal-title":"PloS one"},{"key":"62359_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.105.001503","volume":"114","author":"D Ramzy","year":"2006","unstructured":"Ramzy, D. et al. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 114, 319\u2013326 (2006).","journal-title":"Circulation"},{"key":"62359_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","volume":"76","author":"F B\u00f6hm","year":"2007","unstructured":"B\u00f6hm, F. & Pernow, J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res. 76, 8\u201318. https:\/\/doi.org\/10.1016\/j.cardiores.2007.06.004 (2007).","journal-title":"Cardiovasc. Res."},{"key":"62359_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s001340051154","volume":"26","author":"JS Brauner","year":"2000","unstructured":"Brauner, J. S., Rohde, L. E. & Clausell, N. Circulating endothelin-1 and tumor necrosis factor-alpha: Early predictors of mortality in patients with septic shock. Intensive Care Med. 26, 305\u2013313. https:\/\/doi.org\/10.1007\/s001340051154 (2000).","journal-title":"Intensive Care Med."},{"key":"62359_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1465-9921-13-77","volume":"13","author":"C Pan","year":"2012","unstructured":"Pan, C. et al. Low tidal volume protects pulmonary vasomotor function from \u201csecond-hit\u201d injury in acute lung injury rats. Respir. Res. 13, 77. https:\/\/doi.org\/10.1186\/1465-9921-13-77 (2012).","journal-title":"Respir. Res."},{"key":"62359_CR47","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2215\/CJN.11130919","volume":"15","author":"P Li","year":"2020","unstructured":"Li, P. et al. Plasma endothelin-1 and risk of death and hospitalization in patients undergoing maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 15, 784\u2013793. https:\/\/doi.org\/10.2215\/CJN.11130919 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"62359_CR48","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1111\/jvim.16217","volume":"35","author":"M Ider","year":"2021","unstructured":"Ider, M. et al. Biomarkers in premature calves with and without respiratory distress syndrome. J. Vet. Internal Med. 35, 2524\u20132533 (2021).","journal-title":"J. Vet. Internal Med."},{"key":"62359_CR49","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","volume":"44","author":"SW Xu","year":"2023","unstructured":"Xu, S. W., Ilyas, I. & Weng, J. P. Endothelial dysfunction in COVID-19: An overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol. Sin. 44, 695\u2013709. https:\/\/doi.org\/10.1038\/s41401-022-00998-0 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"62359_CR50","unstructured":"Barber, B. E. et al. Open Forum Infect Di ofw027 (Oxford University Press, 2022)."},{"key":"62359_CR51","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1093\/ndt\/gfg452","volume":"18","author":"RJ Nijveldt","year":"2003","unstructured":"Nijveldt, R. J. et al. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol. Dial. Transplant 18, 2542\u20132550. https:\/\/doi.org\/10.1093\/ndt\/gfg452 (2003).","journal-title":"Nephrol. Dial. Transplant"},{"key":"62359_CR52","first-page":"325","volume":"76","author":"G Iapichino","year":"2010","unstructured":"Iapichino, G. et al. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Miner. Anestesiol. 76, 325\u2013333 (2010).","journal-title":"Miner. Anestesiol."},{"key":"62359_CR53","doi-asserted-by":"publisher","first-page":"H1762","DOI":"10.1152\/ajpheart.01205.2011","volume":"302","author":"M Davids","year":"2012","unstructured":"Davids, M. et al. Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine. Am. J. Physiol. Heart Circ. Physiol. 302, H1762-1770. https:\/\/doi.org\/10.1152\/ajpheart.01205.2011 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"62359_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1475-2875-7-83","volume":"7","author":"V Jain","year":"2008","unstructured":"Jain, V. et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J. 7, 83. https:\/\/doi.org\/10.1186\/1475-2875-7-83 (2008).","journal-title":"Malar. J."},{"key":"62359_CR55","doi-asserted-by":"publisher","first-page":"17097","DOI":"10.1073\/pnas.0805782105","volume":"105","author":"TW Yeo","year":"2008","unstructured":"Yeo, T. W. et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc. Natl. Acad. Sci. 105, 17097\u201317102 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62359_CR56","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1213\/ane.0b013e31816a643f","volume":"106","author":"S Karlsson","year":"2008","unstructured":"Karlsson, S. et al. Vascular endothelial growth factor in severe sepsis and septic shock. Anesth. Analg. 106, 1820\u20131826. https:\/\/doi.org\/10.1213\/ane.0b013e31816a643f (2008).","journal-title":"Anesth. Analg."},{"key":"62359_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12916-015-0365-9","volume":"13","author":"J Hanson","year":"2015","unstructured":"Hanson, J. et al. Microvascular obstruction and endothelial activation are independently associated with the clinical manifestations of severe falciparum malaria in adults: An observational study. BMC Med. 13, 122. https:\/\/doi.org\/10.1186\/s12916-015-0365-9 (2015).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-62359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-62359-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-62359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:15:43Z","timestamp":1717593343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-62359-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["62359"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-62359-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12931"}}